By Sheila Dang, Jonathan Stempel and Tom Hals CARTHAGE, Texas (Reuters) -A Texas judge cleared the way for Kenvue to pay a ...

By Sheila Dang, Jonathan Stempel and Tom Hals CARTHAGE, Texas (Reuters) -A Texas judge won't block Kenvue from paying its ...

Kenvue and Kimberly-Clark are merging in a $32B deal with $2.1B in synergies and major consumer health potential. Learn why ...

美国德州总检察长肯帕克斯顿突然决定将泰诺的生产商告上法庭，理由很直接——他指控这些药企故意隐瞒泰诺可能对儿童大脑发育产生风险的问题。事件曝光后，整个美国舆论立刻沸腾，甚至连药店货架上摆放的泰诺瓶子，看上去都仿佛透着一股“不安全”的气息。

编辑｜BaleiBrandi品创获悉，日前，美国日用消费品巨头金佰利（Kimberly-Clark）宣布将以487亿美元收购露得清母公司Kenvue全部股份。这笔2025年迄今为止最大规模的收购案之一，不仅标志着Kenvue在资本市场上独立发展的终点 ...

Kimberly-Clark's Q3 results shine, but acquisition risks and debt weigh on outlook. Learn why KMB stock is rated HOLD and ...

Kimberly-Clark is buying Tylenol maker Kenvue in a $48.7 billion cash-and-stock deal, creating a massive consumer health ...

11月3日晚间，美国日用消费品巨头金佰利（Kimberly-Clark）宣布将以总价487亿美元收购Kenvue全部股份，这笔交易成为2025年迄今为止最大规模的收购案之一，也标志着Kenvue在资本市场上独立发展的终点与新一轮战略整合的起点。

(Reuters) -A Texas judge on Friday deferred ruling on state Attorney General Ken Paxton's bid to temporarily block Kenvue ...

金佰利 (KMB.US)宣布达成一项交易，将以现金加股票的形式收购泰诺制造商Kenvue (KVUE)的所有流通股。根据双方董事会一致通过的协议，Kenvue的股东将获得每股 3.50 美元的现金以及 0.14625 股金佰利的股票作为对价，该交易每股的估值为 21.01 美元。周一盘前，金佰利股价下跌超过 15%，而Kenvue上涨超过20%。

Kimberly-Clark is laying down $40 billion to buy Kenvue in a massive deal that has puzzled some investors as the Tylenol ...

A Texas state judge won't block Kenvue from paying its scheduled November 26 shareholder dividend, rejecting a request by ...